Latest Posts

Génome Québec is proud to announce that four research teams have received major funding in agriculture, agrifood, health and the environment in Québec.  The funds were awarded for projects under Genome Canada’s Genomic Applications Partnership Program (GAPP). GAPP promotes partnerships between academic researchers and users in order to meet the needs of key sectors, such…

The Biobanque québécoise de la COVID-19 (BQC19), Génome Québec and the Québec COVID – Pandemic Network (QCPN) invite the scientific community to submit their requests for access to the BQC19 data and samples, starting October 15, 2020.   The data-only access process will be continuous and will provide immediate access to currently available data. Currently,…

Daniel Coderre, President and CEO of Génome Québec, is happy to announce the appointment of Stéphanie Lord-Fontaine, PhD as Vice President, Scientific Affairs. The decision was unanimously endorsed by the Board of Directors on September 23, 2020. Ms. Lord-Fontaine will be taking up her duties on October 19, 2020. Ms. Lord-Fontaine has held a wide range…

Génome Québec would like to congratulate Bartha Maria Knoppers, O.C, O.Q, PhD, Professor and Director of the Centre of Genomics and Policy at McGill University who received the prestigious 2020 Till & McCulloch Award for her exceptional ethical, legal, and social implications paper in Science entitled, Biotechnologies nibbling at the legal “human.” Dr. Knoppers’ work establishes a path that will…

The development of novel biomarkers of doping is a key priority for anti-doping research. The challenges for the development and implementation of new biomarkers for anti-doping testing not only involve specific analytical approaches and omics technologies, but also require complementary expertise and research approaches that have been advanced in Quebec for the development of clinical…

In2novation will support entrepreneurship by fostering international collaborations between the academic and research community and the private sector. The France Canada Innovation Platform will assist you free of charge with the prospection of research teams in France and Canada, connection with businesses and academic research centers and financial support of collaborative R&D projects. Deadline to…

Génome Québec is proud to announce funding for a new research project intended to accelerate the discovery of antiviral COVID-19 medications.  This project spearheaded by professors Michael Tyers (IRIC/Université de Montréal), Yoshua Bengio (Mila/Université de Montréal) and Anne Marinier (IRIC/Université de Montréal), the $1 million project combines genomics, artificial intelligence and medicinal chemistry to discover new inhibitors of the…

The President and CEO of Génome Québec, Daniel Coderre, applauds Ottawa’s decision to invest $40 million in research on sequencing the genomes of the virus and of patients to better understand the behaviour and evolution of the virus, as well as the different immune reactions by patients. The initiative is part of a $1 billion…

Dr. Guy Rouleau received the Canada Gairdner Wightman Award 2020 for his outstanding work on identifying and elucidating the general mechanisms of neurological and psychiatric diseases, such as ALS (amyotrophic lateral sclerosis), autism and schizophrenia. The award also recognizes his leadership in the field of Open Science, a new collaborative method of conducting research, which…

Daniel Coderre, President and CEO of Génome Québec, is pleased to announce the appointment of Marc Bergeron to the position of Vice President, Finance, starting April 1, 2020. Mr. Bergeron will be taking over from Claude Lamarre, who is retiring after thirteen years of service. Mr. Bergeron has served as Director, Financial Information for Génome…